Can Fite Biopharma logo

Can Fite Biopharma Share Price (NYSE: CANF)

$0.63

-0.03

(-4.55%)

Last updated on

Check the interactive Can Fite Biopharma Stock chart to analyse performance

Can Fite Biopharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.63
    Today's High:$0.65

    Day's Volatility :3.08%

  • 52 Weeks Low:$0.63
    52 Weeks High:$3.12

    52 Weeks Volatility :79.81%

Can Fite Biopharma Stock Returns

PeriodCan Fite Biopharma LtdIndex (Russel 2000)
3 Months
-41.55%
0.0%
6 Months
-62.79%
0.0%
1 Year
-71.17%
0.0%
3 Years
-92.89%
-4.7%

Can Fite Biopharma Ltd Key Stats

Check Can Fite Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.66
Open
$0.65
Today's High
$0.65
Today's Low
$0.63
Market Capitalization
$12.5M
Today's Volume
$146.6K
52 Week High
$3.12
52 Week Low
$0.63
Revenue TTM
$674.0K
EBITDA
$-8.1M
Earnings Per Share (EPS)
$0.0
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-134.94%

Stock Returns calculator for Can Fite Biopharma Stock including INR - Dollar returns

The Can Fite Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Can Fite Biopharma investment value today

Current value as on today

₹33,662

Returns

₹66,338

(-66.34%)

Returns from Can Fite Biopharma Stock

₹71,622 (-71.62%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Can Fite Biopharma Stock

23%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Can Fite Biopharma Stock from India on INDmoney has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Can Fite Biopharma Stock

Rating
Trend

Can Fite Biopharma Share Price Target

What analysts predicted

Upside of 1050.79%

Target:

$7.25

Current:

$0.63

Can Fite Biopharma share price target is $7.25, a slight Upside of 1050.79% compared to current price of $0.63 as per analysts' prediction.

Can Fite Biopharma Stock Insights

  • Price Movement

    In the last 3 months, CANF stock has moved down by -40.5%
  • Increasing Revenue

    Revenue is up for the last 5 quarters, 155.0K → 179.0K (in $), with an average increase of 3.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -1.97M → -1.96M (in $), with an average increase of 0.4% per quarter
  • CANF vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 141.1%
  • CANF vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 205.7%

Can Fite Biopharma Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$674.0K
↓ 9.29%
Net Income
$-7.9M
↑ 3.22%
Net Profit Margin
-1.2K%
↓ 141.68%

Can Fite Biopharma Technicals Summary

Sell

Neutral

Buy

Can Fite Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Can Fite Biopharma Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Can Fite Biopharma Ltd logo
-4.46%
-62.79%
-71.17%
-92.89%
-96.85%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Can Fite Biopharma Ltd

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. The company was incorporated in 1994 and is headquartered in Ramat Gan, Israel.
Organization
Can Fite Biopharma
Employees
5
CEO
Mr. Motti Farbstein
Industry
Health Technology

Key Management of Can Fite Biopharma Ltd

NameTitle
Dr. Pnina Fishman Ph.D.
Founder, Chief Scientific Officer & Executive Chairperson
Mr. Motti Farbstein
CEO and Chief Financial & Operating Officer
Dr. Sari Fishman Ph.D.
Vice President of Business Development
Dr. Stephen A. Harrison FACP, M.D.
Member of Clinical Advisory Board & Consulting Chief Medical Officer

Important FAQs about investing in CANF Stock from India :

What is Can Fite Biopharma share price today?

Can Fite Biopharma share price today is $0.63 as on at the close of the market. Can Fite Biopharma share today touched a day high of $0.65 and a low of $0.63.

What is the 52 week high and 52 week low for Can Fite Biopharma share?

Can Fite Biopharma share touched a 52 week high of $3.12 and a 52 week low of $0.63. Can Fite Biopharma stock price today i.e. is closed at $0.63, lower by 79.81% versus the 52 week high.

How to invest in Can Fite Biopharma Stock (CANF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Can Fite Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Can Fite Biopharma Shares that will get you 2.3810 shares as per Can Fite Biopharma share price of $0.63 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Can Fite Biopharma Stock (CANF) from India?

Indian investors can start investing in Can Fite Biopharma (CANF) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Can Fite Biopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Can Fite Biopharma share’s latest price of $0.63 as on August 30, 2025 at 1:29 am IST, you will get 15.8730 shares of Can Fite Biopharma. Learn more about fractional shares .

What are the returns that Can Fite Biopharma has given to Indian investors in the last 5 years?

Can Fite Biopharma stock has given -96.85% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?